These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29289701)

  • 21. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.
    van Enkhuizen J; Henry BL; Minassian A; Perry W; Milienne-Petiot M; Higa KK; Geyer MA; Young JW
    Neuropsychopharmacology; 2014 Dec; 39(13):3112-22. PubMed ID: 25005251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania.
    van Enkhuizen J; Geyer MA; Young JW
    Psychopharmacology (Berl); 2013 Feb; 225(3):661-74. PubMed ID: 22945515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating.
    van Enkhuizen J; Minassian A; Young JW
    Behav Brain Res; 2013 Jul; 249():44-54. PubMed ID: 23623885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT.
    Young JW; Geyer MA; Halberstadt AL; van Enkhuizen J; Minassian A; Khan A; Perry W; Eyler LT
    Bipolar Disord; 2020 Feb; 22(1):46-58. PubMed ID: 31025493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin transporter inhibition and 5-HT
    Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
    Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D3 receptor blockade rescues hyper-dopamine activity-induced deficit in novel object recognition memory.
    Chang PK; Yu L; Chen JC
    Neuropharmacology; 2018 May; 133():216-223. PubMed ID: 29407766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D
    Chang PK; Chu J; Tsai YT; Lai YH; Chen JC
    J Biomed Sci; 2020 Jan; 27(1):16. PubMed ID: 31900153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and pharmacological assessment of a potential new mouse model for mania.
    Scotti MA; Lee G; Stevenson SA; Ostromecki AM; Wied TJ; Kula DJ; Gessay GM; Gammie SC
    Physiol Behav; 2011 Jun; 103(3-4):376-83. PubMed ID: 21397618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness.
    Rao A; Sorkin A; Zahniser NR
    Synapse; 2013 Oct; 67(10):668-77. PubMed ID: 23564231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of acute dopamine transporter inhibition on manic-, depressive-like phenotypes, and brain oxidative status in adult zebrafish.
    Canzian J; Borba JV; Ames J; Silva RM; Resmim CM; Pretzel CW; Duarte MCF; Storck TR; Mohammed KA; Adedara IA; Loro VL; Gerlai R; Rosemberg DB
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr; 131():110961. PubMed ID: 38325745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
    Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
    Liao IM; Chen JC
    Behav Brain Res; 2021 Jan; 396():112925. PubMed ID: 32971195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and valproate prevent methylphenidate-induced mania-like behaviors in the hole board test.
    Souza LS; Silva EF; Santos WB; Asth L; Lobão-Soares B; Soares-Rachetti VP; Medeiros IU; Gavioli EC
    Neurosci Lett; 2016 Aug; 629():143-148. PubMed ID: 27353513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.
    Ragu Varman D; Subler MA; Windle JJ; Jayanthi LD; Ramamoorthy S
    Behav Brain Res; 2021 Jun; 408():113267. PubMed ID: 33794225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novelty-related behavior of young and adult dopamine transporter knockout rats: Implication for cognitive and emotional phenotypic patterns.
    Adinolfi A; Carbone C; Leo D; Gainetdinov RR; Laviola G; Adriani W
    Genes Brain Behav; 2018 Apr; 17(4):e12463. PubMed ID: 29406596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-active photoperiod gestation induces psychiatry-relevant behavior in healthy mice but a resiliency to such effects are seen in mice with reduced dopamine transporter expression.
    Kwiatkowski MA; Cope ZA; Lavadia ML; van de Cappelle CJA; Dulcis D; Young JW
    Sci Rep; 2020 Jun; 10(1):10217. PubMed ID: 32576854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
    Fox MA; Panessiti MG; Hall FS; Uhl GR; Murphy DL
    Psychopharmacology (Berl); 2013 Jun; 227(4):685-95. PubMed ID: 23417514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
    Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
    Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.